Canon (7751) Q4 2024 earnings summary

Executive summary

• Net sales for FY 2024 reached a record ¥4.51 trillion, surpassing the previous high from 2007 and meeting the 2025 sales target a year early.

• Excluding a ¥165.1 billion impairment loss in the Medical business, operating profit rose nearly 20% year-over-year, with a 0.9 point improvement in operating profit ratio to 9.9%.

• Net income attributable to Canon Inc. dropped 39.5% to ¥160.0 billion due to the Medical goodwill impairment.

• Year-end dividend increased by ¥5 to ¥80, for a full-year dividend of ¥155.

• Adjusted income before income taxes (excluding Medical goodwill impairment) rose 19.3% to ¥466.3 billion.

Financial highlights

• Net sales grew 7.9% year-over-year to ¥4,509.8 billion.

• Operating profit increased 18.5% to ¥444.9 billion, but fell 25.5% to ¥279.8 billion when including the Medical goodwill impairment.

• Net income rose 22.9% to ¥325.1 billion before impairment, but dropped to ¥160.0 billion after impairment.

• Gross profit margin improved to 47.5%, and net income margin reached 7.2%.

• Free cash flow improved by ¥133.7 billion to ¥309.5 billion.

Outlook and guidance

• FY 2025 net sales projected to rise 5% to ¥4,736.0 billion, with operating profit up 16.7% to ¥519.0 billion and net income up 12% to ¥364.0 billion.

• Targeting an operating profit ratio of 11% or higher and ROE of 10% or higher.

• Dividend to be raised to ¥160 per share, returning to pre-COVID levels, and plans to repurchase ¥100 billion of own shares.

• Growth expected in network cameras, semiconductor lithography, and core products.

• Canon anticipates record sales for a second consecutive year.